Tocilizumab treatments in patients with noninfectious uveitis demonstrated high rates of success at 1 year follow ups.

Sunvozertinib has shown promising results in patients with non–small cell lung cancer with an EGFR exon 20 insertion mutation ...

Baxter International plans to exit China’s intravenous fluids market, multiple local media outlets report, citing a letter to ...

The global peripheral intravenous catheter market is projected to experience robust growth over the next decade, with market size expected to exceed USD 13,006.1 million by 2034, up from USD 6,489.3 ...

Heart of the Rockies Regional Medical Center (HRRMC) has reported that it is feeling the effects of a nationwide shortage of intravenous (IV) fluids. Its main supplier of IV fluids, Baxter ...

Akamis Bio, a clinical-stage oncology company using a proprietary Tumor-Specific Immuno-Gene Therapy (T-SIGn®) platform to ...

Your doctor will determine the best dosage to suit your needs. intravenous (IV) infusion (an injection into a vein that’s given over time), which lasts about 30 minutes liquid solution given by ...

[77] Bolus doses in the range of 625 mg to 2.5 g (12.5–50 mg/kg) have been fatal. Premixed injection solutions are available and may help reduce dosage errors. For patients on diuretic therapy ...

These categories of medications are generally taken orally (by mouth). However, some categories mentioned above have varying ...

ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) research with a focus on healthy aging, today announced the nationwide rollout of its ...

Allakos shifted focus to AK006 in 2024 after lirentelimab's failure in phase 2 trials for atopic dermatitis and CSU. Read why ...